MILWAUKEE, Aug. 7, 2024 /PRNewswire/ -- Ademi LLP is investigating GI (Nasdaq: GTHX) for possible breaches of fiduciary duty and other violations of law in its transaction with Pharmacosmos.Click here to learn how to join our investigation https://www.ademilaw.com/case/g1-therapeutics-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.GI shareholders will receive only $7.15 per share in cash for a total equity value of approximately$405 million. The transaction agreemen ...